Fund code: 299

  • NAV $65.95 -$0.49 / -0.74%
    12-Apr-2024
  • Inception 05-Jun-1997
  • Benchmark MSCI AC World Health Care Index
  • Aggregate assets
    (all series)
    $272.2M
    31-Mar-2024
  • MER 2.25%
    30-Sep-2023
  • Distributions
  • Morningstar category Sector Equity
  • Also available through Trust US$ and Class CDN$
  • Get Fund Facts

End investment

Annualized return

Choose a chart type (percentage or dollar)
Choose a predefined chart period
to:

Start NAV

$10.0000

End NAV

$10.4031
Choose a predefined chart period
to:

Calendar returns (%) 31-Mar-2024

YTD 2024 2023 2022 2021 2020 2019 2018 2017
Fund 9.43 2.95 -7.74 19.22 9.18 18.30 13.84 10.92

Standard period returns (%) 31-Mar-2024

1 mo 3 mo 6 mo 1 yr 3 yr 5 yr 10 yr Inception
Fund 2.77 9.43 14.85 13.37 7.20 8.36 9.99 7.49

Why invest in this fund?

  • Offers exposure to dynamic growth opportunities across the global health care sector.
  • Leverages Fidelity’s expertise in managing industry-specific funds.

Risk measures (%) 31-Mar-2024

Fund
Annualized standard deviation 12.38
Beta 1.08
0.92

Risk classification

  1. Low
  2. Low to medium
  3. Medium
  4. Medium to high
  5. High

This fund has a medium volatility rating

Allocation

Asset mix (%)

29-Feb-2024

Country mix (%)

29-Feb-2024

Sector mix (%)

29-Feb-2024
12 months ago Last month Current month
Pharma Products 26.5 26.6 25.9
Health Care Equipment & Supplies 20.9 18.9 20.5
Health Care Providers & Services 16.0 21.4 20.5
Life Sciences Tools & Services 24.2 20.3 20.2
Biotech. 7.0 7.3 7.3

Top ten holdings

  1. UnitedHealth Group
  2. Thermo Fisher Scientific
  3. Roche Holding
  4. Novo-Nordisk, Cl. B
  5. Stryker
  6. ICON plc
  7. Eli Lilly and Company
  8. Elevance Health
  9. Boston Scientific
  10. AstraZeneca
Total number of holdings 44
Top ten holdings aggregate 48.5%
  1. UnitedHealth Group
  2. Roche Holding
  3. Thermo Fisher Scientific
  4. Novo-Nordisk, Cl. B
  5. Eli Lilly and Company
  6. Elevance Health
  7. AbbVie
  8. Danaher
  9. AstraZeneca
  10. ICON plc
Total number of holdings 42
Top ten holdings aggregate 50.8%
  1. UnitedHealth Group
  2. Roche Holding
  3. Thermo Fisher Scientific
  4. Stryker
  5. Elevance Health
  6. ICON plc
  7. Danaher
  8. AbbVie
  9. Novo-Nordisk, Cl. B
  10. AstraZeneca
Total number of holdings 44
Top ten holdings aggregate 51.0%
  1. UnitedHealth Group
  2. Thermo Fisher Scientific
  3. Roche Holding
  4. Stryker
  5. AbbVie
  6. Danaher
  7. Elevance Health
  8. Boston Scientific
  9. Sonova Holding
  10. Novo-Nordisk, Cl. B
Total number of holdings 45
Top ten holdings aggregate 52.9%
View all